Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INROADS: Etravirine + Darunavir/Ritonavir Dual Therapy in HIV
NCT01199939Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2010
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of etravirine, darunavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Johnson & Johnson. Started May 2010; status: completed.
02
Drugs
etravirinedarunavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01199939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01199939.